SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

Shanghai Pharmaceuticals Holding Co., Ltd

601607

CNE000000C82

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
17.85 ^CNY	+0.22%		+0.34%	+6.69%

Apr. 26	Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%	MT

Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong

February 20, 2024 at 04:00 am EST

The board of directors of Shanghai Pharmaceuticals Holding Co. Ltd. announced that the principal place of business of the Company in Hong Kong has been changed to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong with effect from 20 February 2024.

Latest news about Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%	Apr. 01	MT
Shanghai Pharmaceuticals Holding Co., Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable Before 30 August 2024	Mar. 28	CI
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Shanghai Pharmaceuticals Gets Nod to Register Amiodarone Hydrochloride Injection	Mar. 22	MT
Shanghai Pharma Names Chairman; Vice Chairman Resigns	Mar. 20	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Executive Changes	Mar. 19	CI
Shanghai Pharma Unit's Citicoline Sodium Injection Passes Regulatory Evaluation	Mar. 08	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong	Feb. 20	CI
Shanghai Pharma Receives Approval For New Dosage of Leukemia Drug	Feb. 13	MT
Shanghai Pharma, Yunnan Baiyao Renew Sales, Procurement Deal	Dec. 22	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Joint Company Secretary	Dec. 21	CI
Shanghai Pharmaceuticals Holding Gets Fine for Anti-Monopoly Violations	Dec. 17	MT
China Aproves Phase 1 Clinical Trial of Shanghai Pharma Subsidiary's Capsule for Tumors	Dec. 08	MT
Shanghai Pharma's Ex-Vice President Becomes Sixth Senior Exec to Face Probe	Nov. 23	MT
Shanghai Pharmaceuticals Chairman Steps Down	Nov. 20	MT
SIIC Environment Chairman Resigns	Nov. 19	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Resignation of Zhou Jun as the Chairman of the Company, A Non-Executive Director	Nov. 19	CI
Shanghai Pharmaceuticals' Profit Up 6% in Q3	23-10-27	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Pharma’s Arthrits Drug Passes Generic Drug Consistency Test	23-10-05	MT
Shanghai Pharma’s Antibiotic Passes Generic Drug Consistency Evaluation in China	23-09-08	MT
China's CMOC to boost Congo copper output after ending row with Gecamines	23-09-07	RE
Shanghai Pharma’s Former Execs Face Probe	23-09-04	MT
Shanghai Pharmaceuticals’ H1 Profit Slides 29% Despite 19% Revenue Growth; Shanghai Shares Slump 8%	23-08-30	MT

Chart Shanghai Pharmaceuticals Holding Co., Ltd

Duration

Period

Chart Shanghai Pharmaceuticals Holding Co., Ltd

More charts

Company Profile

Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai Pharmaceuticals Holding Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.85 CNY

Average target price

20.78 CNY

Spread / Average Target

+16.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
MCKESSON CORPORATION	+17.35%	71.39B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B
MEDIPAL HOLDINGS CORPORATION	+7.96%	3.29B

Pharmaceuticals Wholesale